| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing alprostadil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Prostaglandin E>1< preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| E series prostaglandin adverse reaction (disorder) |
Causative agent (attribute) |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone adverse reaction |
Causative agent (attribute) |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Gemeprost adverse reaction |
Causative agent (attribute) |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil adverse reaction |
Causative agent (attribute) |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Allergy to E series prostaglandin (finding) |
Causative agent (attribute) |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Allergy to dinoprostone |
Causative agent (attribute) |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Allergy to gemeprost |
Causative agent (attribute) |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Allergy to alprostadil (finding) |
Causative agent (attribute) |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone 10mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré avec diluant pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone 400 microgram/mL vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone 3 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing gemeprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Gemeprost 1 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 500 microgrammes/mL, ampoule de 1 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 20micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 10micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 5micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 10micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 20micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 10micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 20micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 10micrograms powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 20micrograms powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 125micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 250micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 500micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 1000micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 40micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 40micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 40micrograms powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 20micrograms cartridge syringe injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| alprostadil 10micrograms cartridge syringe injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing dinoprostone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing dinoprostone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 5mcg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 20.2mcg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 40.0mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Dinoprostone 10mg insert |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 10.16mcg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 125mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 250mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 500mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 1000mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil + alprostadil alfadex + lactose, anhydrous 12.45mcg/402.55mcg/56.3mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 500mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing alprostadil in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 20micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
| Alprostadil 10micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin E>1< |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]